246 related articles for article (PubMed ID: 18673122)
1. Strategies for effective naked-DNA vaccination against infectious diseases.
Chiarella P; Massi E; De Robertis M; Fazio VM; Signori E
Recent Pat Antiinfect Drug Discov; 2008 Jun; 3(2):93-101. PubMed ID: 18673122
[TBL] [Abstract][Full Text] [Related]
2. Application of electroporation in DNA vaccination protocols.
Chiarella P; Fazio VM; Signori E
Curr Gene Ther; 2010 Aug; 10(4):281-6. PubMed ID: 20504275
[TBL] [Abstract][Full Text] [Related]
3. DNA vaccines: a mini review.
Saha R; Killian S; Donofrio RS
Recent Pat DNA Gene Seq; 2011 Aug; 5(2):92-6. PubMed ID: 21574950
[TBL] [Abstract][Full Text] [Related]
4. Nucleic acid vaccination strategies against infectious diseases.
Marć MA; Domínguez-Álvarez E; Gamazo C
Expert Opin Drug Deliv; 2015; 12(12):1851-65. PubMed ID: 26365499
[TBL] [Abstract][Full Text] [Related]
5. Improvement of nonviral gene therapy by Epstein-Barr virus (EBV)-based plasmid vectors.
Mazda O
Curr Gene Ther; 2002 Sep; 2(3):379-92. PubMed ID: 12189722
[TBL] [Abstract][Full Text] [Related]
6. From plasmids to protection: a review of DNA vaccines against infectious diseases.
Laddy DJ; Weiner DB
Int Rev Immunol; 2006; 25(3-4):99-123. PubMed ID: 16818367
[TBL] [Abstract][Full Text] [Related]
7. Optimization and delivery of plasmid DNA for vaccination.
Jechlinger W
Expert Rev Vaccines; 2006 Dec; 5(6):803-25. PubMed ID: 17184219
[TBL] [Abstract][Full Text] [Related]
8. Vaccination with Messenger RNA: A Promising Alternative to DNA Vaccination.
Tombácz I; Weissman D; Pardi N
Methods Mol Biol; 2021; 2197():13-31. PubMed ID: 32827130
[TBL] [Abstract][Full Text] [Related]
9. Potential of nanocarriers in genetic immunization.
Khatri K; Goyal AK; Vyas SP
Recent Pat Drug Deliv Formul; 2008; 2(1):68-82. PubMed ID: 19075899
[TBL] [Abstract][Full Text] [Related]
10. Engineering DNA vaccines against infectious diseases.
Lee J; Arun Kumar S; Jhan YY; Bishop CJ
Acta Biomater; 2018 Oct; 80():31-47. PubMed ID: 30172933
[TBL] [Abstract][Full Text] [Related]
11. DNA vaccines: successes and limitations in cancer and infectious disease.
Lowe DB; Shearer MH; Kennedy RC
J Cell Biochem; 2006 May; 98(2):235-42. PubMed ID: 16440328
[TBL] [Abstract][Full Text] [Related]
12. DNA vaccines: an historical perspective and view to the future.
Liu MA
Immunol Rev; 2011 Jan; 239(1):62-84. PubMed ID: 21198665
[TBL] [Abstract][Full Text] [Related]
13. Novel viral vectors in infectious diseases.
Humphreys IR; Sebastian S
Immunology; 2018 Jan; 153(1):1-9. PubMed ID: 28869761
[TBL] [Abstract][Full Text] [Related]
14. Gene-based vaccines and immunotherapeutic strategies against neurodegenerative diseases: Potential utility and limitations.
Kudrna JJ; Ugen KE
Hum Vaccin Immunother; 2015; 11(8):1921-6. PubMed ID: 26125436
[TBL] [Abstract][Full Text] [Related]
15. DNA immunization.
Hassett DE; Whitton JL
Trends Microbiol; 1996 Aug; 4(8):307-12. PubMed ID: 8856868
[TBL] [Abstract][Full Text] [Related]
16. DNA vaccines.
Donnelly JJ; Ulmer JB; Liu MA
Dev Biol Stand; 1998; 95():43-53. PubMed ID: 9855413
[TBL] [Abstract][Full Text] [Related]
17. Bacteria as DNA vaccine carriers for genetic immunization.
Schoen C; Stritzker J; Goebel W; Pilgrim S
Int J Med Microbiol; 2004 Oct; 294(5):319-35. PubMed ID: 15532991
[TBL] [Abstract][Full Text] [Related]
18. T lymphocyte engineering ex vivo for cancer and infectious disease.
Levine BL
Expert Opin Biol Ther; 2008 Apr; 8(4):475-89. PubMed ID: 18352851
[TBL] [Abstract][Full Text] [Related]
19. Plasmid DNA vaccines: where are we now?
Ghaffarifar F
Drugs Today (Barc); 2018 May; 54(5):315-333. PubMed ID: 29911696
[TBL] [Abstract][Full Text] [Related]
20. Cationic transfersomes based topical genetic vaccine against hepatitis B.
Mahor S; Rawat A; Dubey PK; Gupta PN; Khatri K; Goyal AK; Vyas SP
Int J Pharm; 2007 Aug; 340(1-2):13-9. PubMed ID: 17446015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
